Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part I: Update on laboratory tests for the study of monoclonal gammopathies

MLA

Novartis, et al. Recommendations for the Study of Monoclonal Gammopathies in the Clinical Laboratory. A Consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part I: Update on Laboratory Tests for the Study of Monoclonal Gammopathies. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1442723852&authtype=sso&custid=ns315887.

APA

Novartis, Gilead Research Scholars, Astellas Pharma, Janssen Research and Development, Cárdenas, M. C., García-Sanz, R., Puig, N., Pérez-Surribas, D., Flores-Montero, J., Ortiz-Espejo, M., Rubia, J. de la, & Cruz-Iglesias, E. (2023). Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part I: Update on laboratory tests for the study of monoclonal gammopathies.

Chicago

Novartis, Gilead Research Scholars, Astellas Pharma, Janssen Research and Development, María C. Cárdenas, Ramón García-Sanz, Noemi Puig, et al. 2023. “Recommendations for the Study of Monoclonal Gammopathies in the Clinical Laboratory. A Consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part I: Update on Laboratory Tests for the Study of Monoclonal Gammopathies.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1442723852&authtype=sso&custid=ns315887.